The authors showed 73% of 6835 cancers had telomerase reverse transcriptase (TERT) expression and reported that 63% of TERT wild-type tumors in a core set that consisted of 473 T/N pairs expressed TERT, of which 91% showed promoter DNA methylation [24]. This evidence concerns the gene TERT and cancer.